• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Pediatrix Medical Group Inc.

    3/28/25 6:54:13 AM ET
    $MD
    Hospital/Nursing Management
    Health Care
    Get the next $MD alert in real time by email
    DEFA14A 1 md-2025-additional_mater.htm DEFA14A DEFA14A

     

    20

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington D.C. 20549

     

     

     

    SCHEDULE 14A INFORMATION

     

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934 (Amendment No.  )

     

     

     

    Filed by the Registrant ☒

     

    Filed by a Party other than the Registrant ☐

     

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

     

     

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

     

    ☐

    Definitive Proxy Statement

     

     

    ☒

    Definitive Additional Materials

     

     

    ☐

    Soliciting Material under Rule 14a-12

     

    Pediatrix Medical Group, Inc.

    (Name of Registrant as Specified In Its Charter)

     

    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No Fee Required.

     

     

    ☐

    Fee paid previously with preliminary materials.

     

     

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     


     

     

    img46059403_0.jpg

     

    Your vote matters! Pediatrix Medical Group, Inc. Annual Meeting of Shareholders Thursday, May 8, 2025 10:30 AM, Eastern Time Annual Meeting to be held live via the Internet - please visit www.proxydocs.com/MD for more details. You must register to attend the meeting online and/or participate at www.proxydocs.com/MD For a convenient way to view proxy materials, VOTE and obtain directions to attend the meeting go to www.proxydocs.com/MD To vote your proxy while visiting this site, you will need the 12 digit control number in the box below. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. This is not a ballot. You cannot use this notice to vote your shares. We encourage you to access and review all of the important information contained in the proxy materials before voting. Under United States Securities and Exchange Commission rules, proxy materials do not have to be delivered in paper. Proxy materials can be distributed by making them available on the internet. If you want to receive a paper or e-mail copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. In order to receive a paper package in time for this year's meeting, you must make this request on or before April 28, 2025. Your control number Your vote matters! Meeting Materials: Notice of Meeting and Proxy Statement & Annual Report or Form 10-K Important Notice Regarding the Availability of Proxy Materials for the Shareholders Meeting to be held on May 8, 2025 for Shareholders of Record as of March 10, 2025 To order paper materials, use one of the following methods. Internet: www.investorelections.com/MD Call: 1-866-648-8133 Email: [email protected] * If requesting material by e-mail, please send a blank e-mail with the 12 digit control number (located below) in the subject line. No other requests, instructions OR other inquiries should be included with your e-mail requesting material. Have the 12 digit control number located in the box above available when you access the website and follow the instructions. SEE REVERSE FOR FULL AGENDA Copyright © 2025 BetaNXT, Inc. or its affiliates. All Rights Reserved

     


     

     

    img46059403_1.jpg

     

    Pediatrix Medical Group, Inc. Annual Meeting of Shareholders THE BOARD OF DIRECTORS RECOMMENDS A VOTE: FOR ON PROPOSALS 1, 2 AND 3 PROPOSAL 1. Elect eight Directors, each for a term expiring at the next annual meeting or until a successor has been duly elected and qualified; 1.01. Laura A. Linynsky 1.02. Thomas A. McEachin 1.03. Mark S. Ordan 1.04. Michael A. Rucker 1.05. Guy P. Sansone 1.06. John M. Starcher, Jr. 1.07. Shirley A. Weis 1.08. Sylvia J. Young 2. Ratify the appointment of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the 2025 fiscal year; 3. Conduct an advisory vote regarding the compensation of our named executive officers for the 2024 fiscal year; and 4. Consider and act upon such other business as may properly come before the annual meeting.

     


    Get the next $MD alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MD

    DatePrice TargetRatingAnalyst
    12/16/2024Outperform
    Macquarie
    9/26/2024$8.00 → $14.00Hold → Buy
    Jefferies
    6/7/2024$8.00Sell → Hold
    Deutsche Bank
    2/23/2022$32.00 → $31.00Outperform
    Credit Suisse
    12/22/2021$33.00 → $32.00Outperform
    Credit Suisse
    11/4/2021$29.00 → $27.00Market Perform
    SVB Leerink
    9/27/2021$29.00Market Perform
    SVB Leerink
    8/9/2021$30.00 → $32.00Neutral
    Mizuho
    More analyst ratings

    $MD
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Pediatrix Medical Group Reports First Quarter Results

      Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.24 per share for the three months ended March 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.33. For the 2025 first quarter, Pediatrix reported the following results: Net revenue of $458 million; Net income of $21 million; and Adjusted EBITDA of $49 million. "Our strong first quarter results reflect same-unit top-line outperformance versus our expectations, continued steady cost management and the successful results of the portfolio restructuring we completed last year. As a result of our strong f

      5/6/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025

      Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 6, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2025. A detailed press release will be issued the morning of May 6, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across

      4/21/25 7:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Reports Fourth Quarter Results

      Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.51. For the 2024 fourth quarter, Pediatrix reported the following results: Net revenue of $502 million; Net income of $30 million; and Adjusted EBITDA of $69 million. "Our strong fourth quarter results reflect continued top-line outperformance versus our expectations, the completion of our portfolio restructuring, and the related overhead expense reductions," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "I am honored and excited

      2/20/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    SEC Filings

    See more
    • Pediatrix Medical Group Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/8/25 4:30:14 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • SEC Form 10-Q filed by Pediatrix Medical Group Inc.

      10-Q - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/6/25 7:00:19 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Pediatrix Medical Group, Inc. (0000893949) (Filer)

      5/6/25 6:50:08 AM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Macquarie initiated coverage on Pediatrix Medical Group

      Macquarie initiated coverage of Pediatrix Medical Group with a rating of Outperform

      12/16/24 7:46:05 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group upgraded by Jefferies with a new price target

      Jefferies upgraded Pediatrix Medical Group from Hold to Buy and set a new price target of $14.00 from $8.00 previously

      9/26/24 7:37:57 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group upgraded by Deutsche Bank with a new price target

      Deutsche Bank upgraded Pediatrix Medical Group from Sell to Hold and set a new price target of $8.00

      6/7/24 8:14:20 AM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Pediatrix Medical Group Inc.

      SC 13G - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      11/13/24 4:30:24 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Pediatrix Medical Group Inc.

      SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      10/31/24 11:54:57 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • SEC Form SC 13G/A filed by Pediatrix Medical Group Inc. (Amendment)

      SC 13G/A - Pediatrix Medical Group, Inc. (0000893949) (Subject)

      6/10/24 12:43:02 PM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • EVP, GC, Chief Admin Off & Sec Moore Mary Ann E gifted 26,497 shares, decreasing direct ownership by 21% to 100,338 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/7/25 5:00:10 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • EVP, CFO and Treasurer Rossi Kasandra H covered exercise/tax liability with 3,718 shares, decreasing direct ownership by 7% to 51,151 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/4/25 5:00:09 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • EVP, GC, Chief Admin Off & Sec Moore Mary Ann E covered exercise/tax liability with 8,975 shares, decreasing direct ownership by 7% to 126,835 units (SEC Form 4)

      4 - Pediatrix Medical Group, Inc. (0000893949) (Issuer)

      3/4/25 5:00:17 PM ET
      $MD
      Hospital/Nursing Management
      Health Care

    $MD
    Leadership Updates

    Live Leadership Updates

    See more
    • Pediatrix Announces Strategic Initiatives For Enhanced Shareholder Value Creation

      Executive Chair Mark S. Ordan to Return as Chief Executive Officer Company Redoubles Strategic Focus on Physician Practices and Hospital and Health System Relationships Pediatrix Medical Group, Inc. (NYSE:MD) ("Pediatrix" or "the Company"), a leading provider of physician services, today announced a leadership transition to accelerate its progress in executing a transformational strategy designed to create value for shareholders and other stakeholders. To best position Pediatrix to implement the strategy, which is based on recommitting to the highest standards in clinical excellence and strengthening the Company's hospital relationships, the Company's Board of Directors has appointed Ex

      1/13/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Board Appoints Sylvia Young as Independent Director

      Pediatrix Medical Group, Inc. (NYSE:MD), the nation's leading provider of highly specialized health care for women, children and babies, today announced that its board of directors has appointed Sylvia Young, a recognized leader in healthcare and long-term healthcare executive, as an independent director, effective May 12, 2023. Ms. Young, a veteran of hospital administration since 1985, most recently served as President and CEO of the HCA Continental Division, a multi-state regional healthcare system that is part of Hospital Corporation of America (HCA). Prior to her appointment to the Denver-based Division headquarters, Ms. Young served as President of HCA's Sunrise Health System, inclu

      5/4/23 4:05:00 PM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • BurgerFi Appoints Vivian Lopez-Blanco to its Board of Directors

      PALM BEACH, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (NASDAQ:BFI, BFIIW))) ("BurgerFi" or the "Company"), one of the nation's fastest-growing premium fast-casual concepts, has appointed Vivian Lopez-Blanco to its board of directors, effective July 14, 2021. Lopez-Blanco's appointment follows the sudden passing of board member Steven Berrard announced on June 10, 2021. Lopez-Blanco has also been named as the chair of the audit committee and will be serving on the compensation committee and nominating governance committee. Lopez-Blanco is an experienced board member and seasoned finance executive with expertise in organizational transformations and driving prof

      7/15/21 7:30:00 AM ET
      $BFI
      $TAST
      $MD
      Restaurants
      Consumer Discretionary
      Hospital/Nursing Management
      Health Care

    $MD
    Financials

    Live finance-specific insights

    See more
    • Pediatrix Medical Group Reports First Quarter Results

      Raises Full Year 2025 Adjusted EBITDA Outlook Range Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.24 per share for the three months ended March 31, 2025. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.33. For the 2025 first quarter, Pediatrix reported the following results: Net revenue of $458 million; Net income of $21 million; and Adjusted EBITDA of $49 million. "Our strong first quarter results reflect same-unit top-line outperformance versus our expectations, continued steady cost management and the successful results of the portfolio restructuring we completed last year. As a result of our strong f

      5/6/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group 2025 First Quarter Conference Call/Webcast Scheduled for Tuesday, May 6, 2025

      Pediatrix Medical Group, Inc. (NYSE:MD) will host an investor conference call and webcast on Tuesday, May 6, 2025 at 9:00 a.m. ET to discuss results from operations for the quarter ended March 31, 2025. A detailed press release will be issued the morning of May 6, 2025 before the securities markets open. The investor conference call will be webcast and can be accessed at Pediatrix's website, www.pediatrix.com/investors. ABOUT PEDIATRIX MEDICAL GROUP Pediatrix® Medical Group, Inc. (NYSE:MD) is a leading provider of physician services. Pediatrix-affiliated clinicians are committed to providing coordinated, compassionate and clinically excellent services to women, babies and children across

      4/21/25 7:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care
    • Pediatrix Medical Group Reports Fourth Quarter Results

      Pediatrix Medical Group, Inc. (NYSE:MD), a leading provider of physician services, today reported earnings of $0.36 per share for the three months ended December 31, 2024. On a non-GAAP basis, Pediatrix reported Adjusted EPS of $0.51. For the 2024 fourth quarter, Pediatrix reported the following results: Net revenue of $502 million; Net income of $30 million; and Adjusted EBITDA of $69 million. "Our strong fourth quarter results reflect continued top-line outperformance versus our expectations, the completion of our portfolio restructuring, and the related overhead expense reductions," said Mark S. Ordan, Chief Executive Officer of Pediatrix Medical Group. "I am honored and excited

      2/20/25 6:00:00 AM ET
      $MD
      Hospital/Nursing Management
      Health Care